1 Table of Contents: “... Carcinogenesis and for BreastCancer Therapy -- 22. Tumour and Patient Variables as Indicators of Prognosis...”

2 Table of Contents: “...23. United Kingdom: Where Are We Going? -- 24. United States, Private Practice: Where Are We Going...”

3 Table of Contents: “... - responsibility in development, clinical trials and marketing -- 19 United Kingdom regulations relating...”

4 Table of Contents: “... -- 9. The United States of America -- 10. Western Europe -- 11. The United Kingdom -- 12 Immigrants...”

5 Table of Contents: “... metabolic diseases among South Asians in the United Kingdom -- 11. Management of inherited metabolic...”

6 Table of Contents: “... in Neurology -- 5 Drug Development Stages -- 6 Drug Regulatory Requirements in the United Kingdom and Europe...”

7 Table of Contents: “... in Hodgkin’s disease -- 20. Current practice in Hodgkin’s disease: the United Kingdom Children’s Cancer Study...”

8 Table of Contents: “... -- Part VI Contextual -- 64 Ethics -- 65 Health Disparities -- 66 Emergency Oncology in the United Kingdom...”

9 Table of Contents: “...1 Epidemiology -- 1.1 Worldwide comparisons -- 1.2 Within the United Kingdom -- 1.3 Consideration...”

10 Table of Contents: “..., implantable devices and driving “The United Kingdom Advisory Panel Experience”...”

11 Table of Contents: “... Collaboration and Maturation – The United Kingdom Experience -- Chapter 9. Case Study: The Madrid Train Bombing...”

12 Table of Contents: “... ligament: neoplasms -- 22 Ovary: normal appearances and cyclical changes -- 23 Ovary: cysts and tumour-like...”

13 Table of Contents: “... (Somatonorm I) in the United Kingdom -- 22 Clinical Experience with Biosynthetic GrowthHormone (III) --...”

14 Table of Contents: “... following Total Knee Replacement -- Chapter 22: Management of Extensor Mechanism Disruption in Total Knee...”

15 Table of Contents: “...1.5.1 Rectified Linear Unit (ReLU)1.5.2 Dropout; 1.5.3 Batch Normalization; 1.6 Open-Source Tools...”